Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
The incidence of<b> </b>neglected diseases in tropical countries, such as Leishmaniasis and Chagas’s disease, is attributed to a set of biological and ecological factors associated with the socioeconomic context of developing countries and with a significant burden to health ca...
Main Authors: | Eliana B. Souto, João Dias-Ferreira, Sara A. Craveiro, Patrícia Severino, Elena Sanchez-Lopez, Maria L. Garcia, Amélia M. Silva, Selma B. Souto, Sheefali Mahant |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/8/3/119 |
Similar Items
-
Screening of Agelasine D and Analogs for Inhibitory Activity against Pathogenic Protozoa; Identification of Hits for Visceral Leishmaniasis and Chagas Disease
by: ÃÂgnes Proszenyák, et al.
Published: (2009-01-01) -
In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
by: Lina S. Prieto Cárdenas, et al.
Published: (2022-05-01) -
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
by: Hayelom Berhe, et al.
Published: (2024-02-01) -
Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
by: Debora B. Scariot, et al.
Published: (2022-09-01) -
Antimicrobial Activity of Chitosan Oligosaccharides with Special Attention to Antiparasitic Potential
by: Nayara Sousa da Silva, et al.
Published: (2021-02-01)